OceanIQ Capital, LLC’s Bristol-Myers Squibb BMY Stock Holding History

OceanIQ Capital, LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$507K	Buy	+7,970	New	+$458K	0.31%	55

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $751B AUM 15.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OceanIQ Capital, LLC's BMY Position: Q2 2026 in Review

OceanIQ Capital, LLC opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 7,970 shares worth $507K. The stake represents 0.31% of the portfolio and ranks #55 among its holdings.

2,287 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

OceanIQ Capital, LLC held 7,970 shares of Bristol-Myers Squibb worth $507K as of Q2 2026.
Bristol-Myers Squibb was a new OceanIQ Capital, LLC position in Q2 2026.
Bristol-Myers Squibb made up 0.31% of OceanIQ Capital, LLC's portfolio in Q2 2026, its #55 holding.
2,287 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on OceanIQ Capital, LLC's 13F filing for Q2 2026, filed 12 Aug 2026.